Literature DB >> 31271191

H2FPEF Score as a Prognostic Value in HFpEF Patients.

Daisuke Sueta1,2, Eiichiro Yamamoto1,2, Taiki Nishihara1,2, Takanori Tokitsu1,2, Koichiro Fujisue1,2, Fumi Oike1,2, Masafumi Takae1,2, Hiroki Usuku1,2, Seiji Takashio1,2, Yuichiro Arima1,2, Satoru Suzuki1,2, Taishi Nakamura1,2, Miwa Ito1,2, Hisanori Kanazawa1,2, Kenji Sakamoto1,2, Koichi Kaikita1,2, Kenichi Tsujita1,2.   

Abstract

BACKGROUND: The H2FPEF score is recognized as a simple method to diagnose heart failure (HF) with preserved left ventricular ejection fraction (HFpEF). We investigated the value of the H2FPEF score in predicting subsequent cardiovascular events in HFpEF patients.
METHODS: This study was a retrospective, single-center, observational study. We calculated the H2FPEF scores for 404 consecutive HFpEF patients. Subjects were subdivided into low- (0-3), intermediate- (4-6), and high-score (7-9) groups and followed for 50 months. The primary and secondary endpoints were composite cardiovascular/cerebrovascular events (cardiovascular death, nonfatal myocardial infarction, unstable angina pectoris, hospitalization for HF decompensation, and nonfatal stroke) occurrence and HF-related events (hospitalization for HF decompensation) occurrence at 50 months, respectively.
RESULTS: Kaplan-Meier analyses demonstrated a significantly higher incidence of cardiovascular/cerebrovascular events among those with a higher H2FPEF score (log-rank test, P = 0.005). The HF-related event rate was higher in proportion to the H2FPEF score (log-rank test, P < 0.001). Multivariate Cox hazard analyses identified the H2FPEF score (per 1 point) as an independent predictor of cardiovascular and HF-related events (hazard ratio [HR], 1.179; 95% confidence interval [CI], 1.066-1.305; P = 0.001 and HR, 1.288; 95% CI, 1.134-1.463; P = 0.001, respectively). Receiver operating characteristic analysis showed that the H2FPEF significantly predicted cardiovascular events (area under the curve [AUC], 0.626; 95% CI, 0.557-0.693; P < 0.001) and HF-related events (AUC, 0.680; 95% CI, 0.600-0.759; P < 0.001). The cutoff H2FPEF score was 5.5 for the identification of cardiovascular and HF-related events.
CONCLUSION: The H2FPEF score might be a potentially useful marker for the prediction of cardiovascular and HF-related events in HFpEF patients. CLINICAL TRAILS REGISTRATION: Trail Number UMIN000029600. © American Journal of Hypertension, Ltd 2019. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  HFpEF; blood pressure; cardiovascular events; hypertension; risk factors; risk stratification

Year:  2019        PMID: 31271191     DOI: 10.1093/ajh/hpz108

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  18 in total

1.  On the search for the right definition of heart failure with preserved ejection fraction.

Authors:  Agnieszka Kapłon-Cieślicka; Karolina Kupczyńska; Piotr Dobrowolski; Błażej Michalski; Miłosz J Jaguszewski; Waldemar Banasiak; Paweł Burchardt; Łukasz Chrzanowski; Szymon Darocha; Justyna Domienik-Karłowicz; Jarosław Drożdż; Marcin Fijałkowski; Krzysztof J Filipiak; Marcin Gruchała; Ewa A Jankowska; Piotr Jankowski; Jarosław D Kasprzak; Wojciech Kosmala; Piotr Lipiec; Przemysław Mitkowski; Katarzyna Mizia-Stec; Piotr Szymański; Agnieszka Tycińska; Wojciech Wańha; Maciej Wybraniec; Adam Witkowski; Piotr Ponikowski; On Behalf Of "Club 30" Of The Polish Cardiac Society
Journal:  Cardiol J       Date:  2020-09-28       Impact factor: 2.737

Review 2.  Heart Failure with Preserved Ejection Fraction: Pathogenesis, Diagnosis, Exercise, and Medical Therapies.

Authors:  Qingyi Zhan; Wenjing Peng; Siqi Wang; Juan Gao
Journal:  J Cardiovasc Transl Res       Date:  2022-09-28       Impact factor: 3.216

3.  The controlling nutritional status score predicts outcomes of cardiovascular events in patients with heart failure with preserved ejection fraction.

Authors:  Takashi Komorita; Eiichiro Yamamoto; Daisuke Sueta; Takanori Tokitsu; Koichiro Fujisue; Hiroki Usuku; Taiki Nishihara; Fumi Oike; Masafumi Takae; Koichi Egashira; Seiji Takashio; Miwa Ito; Kenshi Yamanaga; Yuichiro Arima; Kenji Sakamoto; Satoru Suzuki; Koichi Kaikita; Kenichi Tsujita
Journal:  Int J Cardiol Heart Vasc       Date:  2020-06-26

4.  Predictive value of H2 FPEF score in patients with heart failure with preserved ejection fraction.

Authors:  Yuxi Sun; Niuniu Wang; Xiao Li; Yanli Zhang; Jie Yang; Gary Tse; Ying Liu
Journal:  ESC Heart Fail       Date:  2021-01-05

5.  The H2FPEF and HFA-PEFF algorithms for predicting exercise intolerance and abnormal hemodynamics in heart failure with preserved ejection fraction.

Authors:  Shiro Amanai; Tomonari Harada; Kazuki Kagami; Kuniko Yoshida; Toshimitsu Kato; Naoki Wada; Masaru Obokata
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

6.  HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction.

Authors:  Koichi Egashira; Daisuke Sueta; Takashi Komorita; Eiichiro Yamamoto; Hiroki Usuku; Takanori Tokitsu; Koichiro Fujisue; Taiki Nishihara; Fumi Oike; Masafumi Takae; Shinsuke Hanatani; Seiji Takashio; Miwa Ito; Kenshi Yamanaga; Satoshi Araki; Hirofumi Soejima; Koichi Kaikita; Kenichi Matsushita; Kenichi Tsujita
Journal:  Korean J Intern Med       Date:  2021-12-21       Impact factor: 2.884

7.  Percutaneous edge-to-edge mitral valve repair for mitral regurgitation improves heart failure symptoms in heart failure with preserved ejection fraction patients.

Authors:  Matthias Gröger; Jinny Karin Scheffler; Florian Schösser; Leonhard Moritz Schneider; Wolfgang Rottbauer; Sinisa Markovic; Mirjam Keßler
Journal:  ESC Heart Fail       Date:  2021-09-09

Review 8.  Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models.

Authors:  Coenraad Withaar; Carolyn S P Lam; Gabriele G Schiattarella; Rudolf A de Boer; Laura M G Meems
Journal:  Eur Heart J       Date:  2021-11-14       Impact factor: 29.983

Review 9.  Heart failure with preserved ejection fraction: insights from recent clinical researches.

Authors:  Mi-Na Kim; Seong-Mi Park
Journal:  Korean J Intern Med       Date:  2020-04-29       Impact factor: 2.884

10.  Prognostic value of the H2 FPEF score in patients undergoing transcatheter aortic valve implantation.

Authors:  Sebastian Ludwig; Costanza Pellegrini; Alina Gossling; Tobias Rheude; Lisa Voigtländer; Oliver D Bhadra; Matthias Linder; Daniel Kalbacher; Benedikt Koell; Lara Waldschmidt; Johannes Schirmer; Moritz Seiffert; Hermann Reichenspurner; Stefan Blankenberg; Dirk Westermann; Lenard Conradi; Michael Joner; Niklas Schofer
Journal:  ESC Heart Fail       Date:  2020-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.